Vitruvias Therapeutics recalls

FDA enforcement reports naming VITRUVIAS THERAPEUTICS INC as the recalling firm.

Recall reports: 1
Class I (serious): 1
Most recent report: Sep 23, 2026

Severity

Sep 23, 2026Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mc…Drug · VITRUVIAS THERAPEUTICS INCSuperpotent DrugClass I